Search - tctmd.com

Displaying 141 - 160 of 291

Sort: Relevancy | Date

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Presentation TCT 2019

Assessment of Transcatheter Aortic Valve Regurgitation: Guidelines and Beyond

Presenter: William Zoghbi

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

Presenter: Mohammad Abdelghani

September 25, 2019

Presentation TCT 2019

TAVR in Pure Aortic Regurgitation

Presenter: Thomas Pilgrim

September 25, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

TAVR to Treat Pure Aortic Regurgitation: The TVT Registry Experience

Presenter: Susheel K. Kodali, Vinod H. Thourani, Saif Anwaruddin

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

FORMA: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

Presenter: Martin B. Leon, Susheel K. Kodali

November 02, 2017

Presentation TCT 2017

TRI-REPAIR: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

Presenter: Martin B. Leon, Georg Nickenig

November 02, 2017

Presentation TCT 2017

TAVR in Symptomatic High-risk Aortic Regurgitation: Case Selection, Devices and Preliminary Clinical Outcomes

Presenter: Ariel Finkelstein, Ran Kornowski, Hendrik Treede

November 01, 2017

Presentation TCT 2017

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Advertisement

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

TCT 2019 Day Two: Transcatheter Valves, New and Old

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Assessment of Transcatheter Aortic Valve Regurgitation: Guidelines and Beyond

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

TAVR in Pure Aortic Regurgitation

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

TAVR to Treat Pure Aortic Regurgitation: The TVT Registry Experience

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

FORMA: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

TRI-REPAIR: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation

TAVR in Symptomatic High-risk Aortic Regurgitation: Case Selection, Devices and Preliminary Clinical Outcomes

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Live From Denver: TCT 2017, Day Three

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content